Technology areas: Biotechnology & Pharmaceuticals • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
8 pending office actions • 4 clients • 7 examiners • 6 art units • 0 of 8 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
TEMMERMAN LAW has 8 pending office actions in Biotechnology & Pharmaceuticals. Its profile records 620 career applications, giving the active workload context within the firm’s prosecution record.
The resolved allowance rate is 83.85%, and the average is 3.1 office actions per allowance. Resolved matters often reach allowance, while the average indicates that multiple examination exchanges are customary before allowance. Practitioners may evaluate response sequencing and claim amendment practice in biotechnology and pharmaceutical matters.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (38%) |
| §112 only | 2 (25%) |
| Multi-statute (no §101) | 2 (25%) |
| No statute on record | 1 (12%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHOSTAK, ANDREY | 2 | 52.4% | +61.8% |
| PARSLEY, DAVID J | 1 | 54.1% | +28.7% |
| SADLON, JOSEPH | 1 | 63.4% | +26.5% |
| LACHICA, ERICSON M | 1 | 29.8% | +35.2% |
| KHAN, AMINA S | 1 | 47.6% | +43.0% |
| GALSTER, SAMUEL LEONARD | 1 | 52.1% | +42.2% |
| LEE, HOI YAN NMN | 1 | 37.5% | +76.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18614248 | BLOOD HEALTH MONITORING METHOD AND DEVICE FOR DETECTING AN ANALYTE EXCRETED BY HUMAN SKIN | SHOSTAK, ANDREY | 27d |
| 18205598 | BLOOD HEALTH MONITORING METHOD AND DEVICE | SHOSTAK, ANDREY | 27d |
| 18755489 | FUNCTIONAL GUM COMPRISING AN ALGINATE BLEND | LACHICA, ERICSON M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17856527 | ALGINATE, POLYLYSINE, AND SEED PRESERVATIVE NUTRITIONAL PRODUCT AND DIGESTIVE AID | LEE, HOI YAN NMN | 23d overdue |
| 17856542 | METHOD FOR NEUTRALIZING STOMACH ACID USING ALGINATE, POLYLYSINE, AND SEED PRESERVATIVES | GALSTER, SAMUEL LEONARD | 15d overdue |
| 18614248 | BLOOD HEALTH MONITORING METHOD AND DEVICE FOR DETECTING AN ANALYTE EXCRETED BY HUMAN SKIN | SHOSTAK, ANDREY | 27d |
| 18205598 | BLOOD HEALTH MONITORING METHOD AND DEVICE | SHOSTAK, ANDREY | 27d |
| 19306889 | MYCELIUM GROWTH BED WITH PERFORATION LAYER AND RELATED METHOD FOR CREATING A UNIFORM SHEET OF MYCELIUM FROM A SOLID-STATE MEDIUM | PARSLEY, DAVID J | — |
| 19190701 | Waterproofing Mounting System for Attaching Solar Modules to a Roof | SADLON, JOSEPH | — |
| 18755489 | FUNCTIONAL GUM COMPRISING AN ALGINATE BLEND | LACHICA, ERICSON M | — |
| 18611594 | Mycelial Leather Replacement Compositions with Improved Affinity to Anionic Aqueous Chemistry | KHAN, AMINA S | — |
| Client (Assignee) | Pending OAs |
|---|---|
| REFLUX GOURMET LLC | 3 |
| MycoWorks | 2 |
| SCOSCHE INDUSTRIES, INC. | 2 |
| Wencon Development, Inc., Dba Quick Mount Pv | 1 |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1693 | 2 |
| 3643 | 1 |
| 3633 | 1 |
| 1617 | 1 |
| 1761 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19306889 | MYCELIUM GROWTH BED WITH PERFORATION LAYER AND RELATED METHOD FOR CREATING A UNIFORM SHEET OF MYCELIUM FROM A SOLID-STATE MEDIUM | Mycoworks, Inc. | PARSLEY, DAVID J | 3643 | §112 | Non-Final OA | — | Pending | Aug 21, 2025 |
| 19190701 | Waterproofing Mounting System for Attaching Solar Modules to a Roof | Wencon Development, Inc., Dba Quick Mount Pv | SADLON, JOSEPH | 3633 | Other | Non-Final OA | — | Pending | Apr 27, 2025 |
| 18755489 | FUNCTIONAL GUM COMPRISING AN ALGINATE BLEND | Reflux Gourmet LLC | LACHICA, ERICSON M | 1617 | §103 | Non-Final OA | — | Pending | Jun 26, 2024 |
| 18614248 | BLOOD HEALTH MONITORING METHOD AND DEVICE FOR DETECTING AN ANALYTE EXCRETED BY HUMAN SKIN | Scosche Industries, Inc. | SHOSTAK, ANDREY | 3791 | §102§103§112 | Non-Final OA | 27d | Pending | Mar 22, 2024 |
| 18611594 | Mycelial Leather Replacement Compositions with Improved Affinity to Anionic Aqueous Chemistry | Mycoworks, Inc. | KHAN, AMINA S | 1761 | §112 | Non-Final OA | — | Pending | Mar 20, 2024 |
| 18205598 | BLOOD HEALTH MONITORING METHOD AND DEVICE | Scosche Industries, Inc. | SHOSTAK, ANDREY | 3791 | §102§103§112 | Non-Final OA | 27d | Pending | Jun 05, 2023 |
| 17856542 | METHOD FOR NEUTRALIZING STOMACH ACID USING ALGINATE, POLYLYSINE, AND SEED PRESERVATIVES | Reflux Gourmet LLC | GALSTER, SAMUEL LEONARD | 1693 | §103 | Final Rejection | 15d overdue | Pending | Jul 01, 2022 |
| 17856527 | ALGINATE, POLYLYSINE, AND SEED PRESERVATIVE NUTRITIONAL PRODUCT AND DIGESTIVE AID | Reflux Gourmet LLC | LEE, HOI YAN NMN | 1693 | §103 | Final Rejection | 23d overdue | Pending | Jul 01, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial83.8% of resolved applications prosecuted by Temmerman Law were allowed, across 620 applications in USPTO records.
3.10 office actions per allowed application on average.
8 pending office actions as of October 2026, for 4 clients, before 7 examiners in 6 art units.
